During the past decade, Samodzielny Publiczny Szpital Kliniczny Nr 2 PUM w Szczecinie conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 10 clinical trials were completed, i.e. on average, 83.3% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 5 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Samodzielny Publiczny Szpital Kliniczny Nr 2 PUM w Szczecinie" #1 sponsor was "Actelion" with 2 trials, followed by "BackBeat Medical Inc" with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored and "Astellas Pharma Europe Ltd." with 2 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Samodzielny Publiczny Szpital Kliniczny Nr 2 PUM w Szczecinie" #1 collaborator was "Abbott" with 1 trials as a collaborator, "Boston Scientific Corporation" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Cordis Corporation" with 1 trials as a collaborator and "Daiichi Sankyo, Inc." with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Samodzielny Publiczny Szpital Kliniczny Nr 2 PUM w Szczecinie" are "Acute Myocardial Infarction" (1 trials), "Acute Peripheral Arterial Occlusion" (1 trials), "Aortic Aneurysm, Abdominal" (1 trials), "Atrial Fibrillation" (1 trials) and "Atrioventricular Block" (1 trials). Many other conditions were trialed in "Samodzielny Publiczny Szpital Kliniczny Nr 2 PUM w Szczecinie" in a lesser frequency.

Most popular intervention types in "Samodzielny Publiczny Szpital Kliniczny Nr 2 PUM w Szczecinie" are "Drug" (12 trials), "Device" (5 trials), "Other" (4 trials) and "Biological" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Atezolizumab" (1 trials), "Atezolizumab Placebo" (1 trials), "Bevacizumab" (1 trials) and "Blood Sample" (1 trials). Other intervention names were less common.

The vast majority of trials in "Samodzielny Publiczny Szpital Kliniczny Nr 2 PUM w Szczecinie" are 20 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Samodzielny Publiczny Szpital Kliniczny Nr 2 PUM w Szczecinie". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Samodzielny Publiczny Szpital Kliniczny Nr 2 PUM w Szczecinie, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Samodzielny Publiczny Szpital Kliniczny Nr 2 PUM w Szczecinie, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 3 trials that are defined as “Not Applicable".

Samodzielny Publiczny Szpital Kliniczny Nr 2 PUM w Szczecinie has several departments that took part in Clinical trials: "SPSK2 PUM, Klinika Kardiologii" - 2 trials